Business Segments · Percent of Revenue Contributed

Biopharma Laboratory Services — Percent of Revenue Contributed

Labcorp Holdings Biopharma Laboratory Services — Percent of Revenue Contributed remained flat by 0.0% to 22.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 22.0% to 22.0%.

Analysis

StatementSegment
CategoryMarket Position
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026

How to read this metric

An increase suggests the segment is growing faster than the rest of the company, while a decrease indicates a shift in revenue mix toward other business areas.

Detailed definition

This metric represents the proportion of total corporate revenue generated by the Biopharma Laboratory Services segment....

Peer comparison

Commonly reported by diversified healthcare and life sciences companies to show segment concentration.

Metric ID: lh_segment_biopharma_laboratory_services_percent_of_revenue_contributed

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value5.8%5.8%5.8%5.8%5.8%5.8%5.8%5.8%22%22%22%22%22%22%22%
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%+282.6%+0.0%+0.0%+0.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+0.0%+282.6%+282.6%+282.6%+0.0%+0.0%+0.0%+0.0%
Range5.8%22%
CAGR+46.7%
Avg YoY Growth+77.1%
Median YoY Growth+0.0%
Current Streak14+ quarters growth

Frequently Asked Questions

What is Labcorp Holdings's biopharma laboratory services — percent of revenue contributed?
Labcorp Holdings (LH) reported biopharma laboratory services — percent of revenue contributed of 22.0% in Q1 2026.
How has Labcorp Holdings's biopharma laboratory services — percent of revenue contributed changed year-over-year?
Labcorp Holdings's biopharma laboratory services — percent of revenue contributed decreased by 0.0% year-over-year, from 22.0% to 22.0%.
What does biopharma laboratory services — percent of revenue contributed mean?
The percentage of total company revenue coming from the Biopharma Laboratory Services business unit.